OPEN LETTER FROM INTERNATIONAL ORGANISATIONS TO THE WHO ON THE ISSUE OF VACCINE SAFETY

To the World Health Organisation and those attending the meeting of the Global Vaccine Quality Control Laboratories Network (Rome 25th-27th, September 2018)

To the European Parliament, the European Medicines Agency and the European Directorate for the Quality of Medicines

By sharing science and joining efforts towards better health, your organisation has improved the lives of millions of people, and we are grateful for this. Providing better nutrition, clean water, improved hygiene, and access to medical care, mortality and infectious disease have been drastically reduced. Your extraordinary communication campaign to detect cases of disease and their contacts, and isolate them, finally led to the eradication of the once devastating smallpox.1 These are great achievements and these noble goals should be further pursued. Today however, we are facing a new epidemic: chronic disease. In the USA, one in two adults has a chronic disease and one in four has two or more.2

Obesity, asthma, cancer, immune and autoimmune diseases, neurological and developmental disorders, are ‘lifestyle diseases’ mainly caused or aggravated by bad nutrition and toxic load. Vaccines are administered to healthy individuals to prevent targeted infections, but their long-term impact on the immune system and their potential role in chronic disease is not being evaluated. Individual risk of poor outcomes to both infection and vaccination varies widely and mass vaccination without proper discrimination at the individual level has led to injuries, death, and unintended consequences. Recently, independent researchers and laboratories have discovered that many vaccines are contaminated with retroviruses 3 and polluted by nanoparticles 4. High levels of aluminium associated with vaccine adjuvants have been found in the brains of autistic children or in people suffering from neurological disorders such as Alzheimer’s disease.5, 6

In your previous meeting you advocated for less independent testing, considered ‘redundant’, in order to speed up the supply of products.7 The recent administration of 250,000 defective vaccines in China 8, the tragedy of the oral polio campaign in

India with over 450,000 cases of paralysis and death 9, the damage caused by the Dengue vaccine in the Philippines 10, reports from all over the world of chronic pain and paralysis after administration of the HPV vaccine,11,12 show that vaccine safety and efficacy are being tragically disregarded in this drive for fast-tracking approval and easy certification.



